Webinar

PET/CT and MR Neuroimaging Methods to Study Alzheimer’s Disease

October 6th, 15:00 CEST

Key Learning Points

Neurodegenerative diseases
Alzheimer’s disease
Neuroimaging
Marmosets
PET/CT
MRI
Awake multimodal imaging
18F-FDG
11C-Pittsburgh Compound B (PiB)

What to expect?

This webinar will attract academic researchers, postgraduate students, principal investigators, and researchers in the pharmaceutical sector, particularly in drug development, working to fight neurodegenerative diseases. This webinar will benefit those working with small animals for drug discovery research seeking to understand better the role of cutting-edge imaging methods to complement their existing research programs.

Topic Input value is invalid.

First name

Last name

Work Phone

Job Title

Company

Country

Work Area

Please choose the Application area

Are you already in contact with your Bruker representative regarding any product inquiries?

Please choose an option

We constantly want to improve our service for our customers. In answering the following question you help us to serve your needs even better in the future: What best describes your situation?

What best describes your situation

I consent to receive occasional emails from Bruker Corporation and its affiliates within the Bruker Group. These emails may include information about upcoming events, webinars, products and services, surveys, and Bruker’s corporate news. I can opt out of these emails at any time.

To learn how Bruker handles my personal data, please read Bruker´s Privacy Notice and Terms of Use.

I agree to share my contact details with Bruker Corporation and its affiliates within the Bruker Group for the purpose of proceeding with my registration.

Topic Input value is invalid.

Already registered and lost your invitation link?

Just fill in your email and you will receive the link to join/watch the event.

Mail

Already registered and lost your invitation link?

Thank you. The invitation link has been resent.

Summary

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder affecting nearly 55 million people worldwide and is expected to increase over the next several years. Our limited understanding of the mechanisms that trigger the emergence of AD has contributed to the lack of interventions that stop, prevent, or fully treat this disease.

We are working to establish the marmoset as the first primate-specific model to reveal the earliest cellular and molecular events of AD processes and allow charting of AD progression from its inception. We believe that the simultaneous assessment of genetic, molecular, functional, behavioral, and pathological phenotypes in marmosets will provide translatable knowledge of the origins and progression of AD in human populations. In this webinar, I will describe our use of multimodal neuroimaging techniques to evaluate AD-related phenotypes in our marmoset AD models, carrying all imaging in conscious, fully awake animals, thus avoiding the confounds of anesthesia.

Speakers

Afonso Silva

Endowed Professor of Translational Neuroimaging & Neurobiology at the University of Pittsburgh

Afonso Silva is an Endowed Professor of Translational Neuroimaging & Neurobiology at the University of Pittsburgh. He is a neuroscientist with extensive training and experience in developing and applying multimodal neuroimaging methods to study the anatomical and functional organization of the brain. Dr. Silva is an expert in working with marmosets, a New World non-human primate with several advantages as an experimental model in neuroscience and neurological disorders.